Court denies TRA an injunction against Kantar’s RapidView
Both the RapidView product and TRA’s own Media TRAnalytics tool combine TV viewing information with purchase data with a view to better targeting ad spend.
TRA accuses Kantar – whose parent company WPP is an investor in TRA – of stealing trade secrets and infringing its patent for a process for “analysing return on investment of advertising campaigns by matching multiple data sources”, allegations denied by Kantar.
The two sides are set to begin mediation soon on the bulk of the claims, but in the meantime TRA sought an injunction to prevent RapidView from being sold by Kantar.
New York District Court Judge Shira Scheindlin rejected TRA’s motion last week, finding that Kantar and its WPP sister company Cavendish “have raised a substantial question about the validity” of the claim on which TRA bases its injunction request.
The claim in question, claim 71 of patent number 7,729,940, covers five steps: from the collection of data, to the matching of information household by household, to storing it, cleaning and editing it and generating a planning report based on the matched data.
But in reviewing Kantar and Cavendish’s submissions, Judge Scheindlin found that “substantially all of the limitations in Claim 71” were “taught” by “prior art” – patent-speak for information already in the public domain.
“I further find that it would have been obvious to a person reasonably skilled in the art to attempt to combine these teachings, even though no single device embodied them all,” she wrote in a 22-page opinion.

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments